This picture for day 130 of #LMB365 by Thomas Mund shows a confocal image of the GFP-stained cytoskeletal remnants of a HeLa cell, an immortal cell line used in scientific research at the LMB. Sometimes beauty lies beyond what you are originally looking for…
Image365
LMB 365 – Day 129
Day 129 of #LMB365 shows Michael Levitt when he joined the scientific staff at the LMB in 1974. Michael was born on this day in 1947, in Pretoria, South Africa. He was awarded the Nobel Prize in Chemistry in 2013 for the development of multiscale models for complex chemical systems
LMB 365 – Day 128
Day 128 of #LMB365 shows Bob Horvitz when he joined the LMB as a postdoctoral visitor in 1974. Bob was born on this day in 1947, in Chicago, USA. He shared the Nobel Prize in Chemistry in 2002 for the discoveries concerning the genetic regulation of organ development and programmed cell death in C. elegans
LMB 365 – Day 127
As the first outpatients are welcomed to the new state-of-the-art Royal Papworth hospital here on the Cambridge Biomedical Campus, on day 127 of #LMB365 we share a photo of our new neighbours with the LMB building behind. Welcome to the campus!
LMB 365 – Day 126
Day 126 of #LMB365 was taken ahead of a recent meeting where members of HR, Finance, the Divisional Administrators and other support staff get together to share news and discuss ways to improve how things work across the LMB to support our scientists. Their invaluable support helps ensure the smooth running of the LMB, allowing scientists to concentrate on what they do best…
LMB 365 – Day 125
LMB scientists use mouse models of human diseases in their research where there are no suitable alternatives. The image for day 125 of #LMB365 shows a genetically modified mouse with a black and white patchwork coloured coat. This mouse is known as a chimera and results from the injection of genetically modified embryonic stem (ES) cells derived from a black mouse, into a donor blastocyst from a white wild type mouse. This technique provides LMB researchers with physiologically relevant mouse models of human diseases, including Alzheimer’s, cancer and asthma, with the aim of identifying a new therapy or cure.